MedPath

ReaDySpeech: clinical testing

Phase 1
Completed
Conditions
Topic: Stroke
Subtopic: Rehabilitation
Disease: Therapy type
Circulatory System
Registration Number
ISRCTN90031373
Lead Sponsor
niversity of Manchester
Brief Summary

1. 2016 results in https://doi.org/10.1080/2331205X.2016.1257410 (added 24/01/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
12
Inclusion Criteria

Inclusion criteria for clinicians: Clinicians will be recruited from 4 North West NHS sites that have already agreed to be involved in both the preliminary testing phase of the study and the future feasibility study. These clinicians will have a stroke caseload.

Inclusion criteria for patient participants:
1. Patients with dysarthria as a result of stroke as diagnosed by a speech and language therapist
2. Patients more than 12 weeks post stroke with no upper limit post stroke
3. Patients who are willing to trial the computer based programme ReaDySpeech.
4. Participants will present with dysarthria, willing and able to undertake communication therapy (in clinicians' opinion)
5. Sufficient ability in English to participate in therapy without a translator
6. Medically stable
7. Able to give informed consent to participate

Exclusion Criteria

There is no clinician exclusion criteria.

Patient participant exclusion criteria:
1. Patients with cognitive or language difficulties that will prevent them giving informed consent or using a computer
2. Patients with insufficient grasp of English

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Structured and open questions following testing phase of the intervention. The questions intend to find out training needs for patients and clinicians as well as support needs for patients and clinician.
Secondary Outcome Measures
NameTimeMethod
Adherence to the online programme. Measured by online history of interaction.
© Copyright 2025. All Rights Reserved by MedPath